https://www.selleckchem.com/pr....oducts/way-316606.ht
In the clinical trial, we found that CAR-T cells peaked at 7-21 days after infusion and lasted for 420 days in peripheral blood of patients. Simultaneously, mild side effects were observed, which could be effectively controlled within 2months in these patients. CAR-T cells can expand themselves with or without target cells in mice, and persist for a long time in NHL patients without serious side effects. The registration date of the clinical trial is May 17, 2018 and the trial registration numbers is NCT03528421 . The registration da
Like
Comment
Share
